PRTX-100 and methotrexate in patients with active rheumatoid arthritis: A Phase Ib randomized, double-blind, placebo-controlled, dose-escalation study.

about

Emerging drugs for immune thrombocytopenia (ITP).Insights from engineering the Affibody-Fc interaction with a computational-experimental method.A highly purified form of staphylococcal protein A alleviates murine immune thrombocytopenia (ITP).

P2860

Q33439789-F6672C00-00B7-49A9-BE8B-4092C815223E Q36363452-CB732B97-C401-4E18-89B5-A267F7C17606 Q47630592-6DEEC4E7-BA6B-4BFE-B5AE-6A71A274CDC6

P2860

PRTX-100 and methotrexate in patients with active rheumatoid arthritis: A Phase Ib randomized, double-blind, placebo-controlled, dose-escalation study.

Item

http://www.wikidata.org/entity/Q39809621

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

PRTX-100 and methotrexate in p ...... rolled, dose-escalation study.

@en

PRTX-100 and methotrexate in p ...... rolled, dose-escalation study.

@nl

type

Item

label

PRTX-100 and methotrexate in p ...... rolled, dose-escalation study.

@en

PRTX-100 and methotrexate in p ...... rolled, dose-escalation study.

@nl

prefLabel

PRTX-100 and methotrexate in p ...... rolled, dose-escalation study.

@en

PRTX-100 and methotrexate in p ...... rolled, dose-escalation study.

@nl

P1476

PRTX-100 and methotrexate in p ...... rolled, dose-escalation study.

@en

P2093

Eduard Kranz

http://www.w3.org/2001/XMLSchema#string

Edward Bernton

http://www.w3.org/2001/XMLSchema#string

William Gannon

http://www.w3.org/2001/XMLSchema#string

William Kramer

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: structural basis for recognition of B-cell receptors and superantigen activity

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Evidence for proteolytic cleavage of covalently bound protein A from a silica based extracorporeal immunoadsorbent and lack of relationship to treatment effects.

IgG Fc receptor polymorphisms in human disease: implications for intravenous immunoglobulin therapy.

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

The Prosorba column for treatment of refractory rheumatoid arthritis: a randomized, double-blind, sham-controlled trial.

On the mechanism of staphylococcal protein A immunomodulation.

Co-opting endogenous immunoglobulin for the regulation of inflammation and osteoclastogenesis in humans and mice.

Use of clinical disease activity index score for assessment of disease activity in rheumatoid arthritis patients: an Indian experience.

Triad of acute infusion-related reactions associated with liposomal amphotericin B: analysis of clinical and epidemiological characteristics.

P304

477-486

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CPDD.116

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27129122

http://www.w3.org/2001/XMLSchema#string

P921

placebo

PRTX-100 and methotrexate in patients with active rheumatoid arthritis: A Phase Ib randomized, double-blind, placebo-controlled, dose-escalation study.

about

P2860

P2860

PRTX-100 and methotrexate in patients with active rheumatoid arthritis: A Phase Ib randomized, double-blind, placebo-controlled, dose-escalation study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921